Interestingly, for RFS, elevated HAND2-AS1 expression was significantly associated with decreased PFS in breast cancer, colon cancer, hepatocellular carcinoma, and non-small cell lung cancer (Fig. 7D). This evidence concerns the gene HAND2 and hepatocellular carcinoma.